Skip to main content
. 2023 Jun 22;11(4):e03234-22. doi: 10.1128/spectrum.03234-22

TABLE 1.

Agreement of Roche and Ortho platforms for all S/NC reactivity classifications

Roche
Ortho S-/NC- S-/NC+ S+/NC- S+/NC+
S-/NC- 1332 4 71 0
S-/NC+ 7 6 0 0
S+/NC- 28 0 1398 2
S+/NC+ 0 4 18 1033